Compare · head to head
Kura Oncology vs Sarepta Therapeutics
Sarepta Therapeutics ranks higher overall — 360 rank 69 vs 30.
Sarepta Therapeutics leads on Value (64 vs 36) and Quality (70 vs 35). Kura Oncology leads on Growth (54 vs 46), Safety (46 vs 40) and Sentiment (58 vs 50).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Large |
| ISIN | US50127T1097 | US8036071004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 30 | 69 |
| Value | 36 | 64 |
| Quality | 35 | 70 |
| Growth | 54 | 46 |
| Safety | 46 | 40 |
| Sentiment | 58 | 50 |
| Quality details | ||
| Profitability | 19 | 75 |
| Cash Truth | 52 | 64 |
Kura Oncology vs Rigel PharmaceuticalsKura Oncology vs Rhythm PharmaceuticalsKura Oncology vs Enanta PharmaceuticalsAdd a third stock →
Full analyses: Kura Oncology · Sarepta Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100